-
1
-
-
0342941143
-
Immunohistochemical detection of p53 protein in rhabdomyosarcoma: Association with clinicopathological features and outcome
-
Ayan I, Dogan O, Kebudi R, Bavbek B, Alatli C, Dervisoglu S, Disci R and Demiryont M (1997) Immunohistochemical detection of p53 protein in rhabdomyosarcoma: Association with clinicopathological features and outcome. J. Ped. Hematol/ Oncol 19 48-53
-
(1997)
J. Ped. Hematol/ Oncol
, vol.19
, pp. 48-53
-
-
Ayan, I.1
Dogan, O.2
Kebudi, R.3
Bavbek, B.4
Alatli, C.5
Dervisoglu, S.6
Disci, R.7
Demiryont, M.8
-
2
-
-
0030861438
-
The SWISS-PROT protein sequence data bank and its supplement TrEMBL
-
Bairoch A and Apweiler R (1997) The SWISS-PROT protein sequence data bank and its supplement TrEMBL. Nucleic Acids Res. 25: 31-36
-
(1997)
Nucleic Acids Res.
, vol.25
, pp. 31-36
-
-
Bairoch, A.1
Apweiler, R.2
-
3
-
-
0022483186
-
Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression
-
Banks L, Matlashiewski G and Crawform L (1986) Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159: 529-534
-
(1986)
Eur. J. Biochem.
, vol.159
, pp. 529-534
-
-
Banks, L.1
Matlashiewski, G.2
Crawform, L.3
-
4
-
-
0031040125
-
p53 Protein in pediatric malignant astrocytomas: A Study of 21 patients
-
Bhattacharjee MB and Bruner JM (1997) p53 Protein in pediatric malignant astrocytomas: A Study of 21 patients. J Neuro-Oncol. 32: 225-233
-
(1997)
J Neuro-Oncol.
, vol.32
, pp. 225-233
-
-
Bhattacharjee, M.B.1
Bruner, J.M.2
-
5
-
-
0026609019
-
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
-
Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF and Linnoila RI (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogens 7: 743-749
-
(1992)
Oncogens
, vol.7
, pp. 743-749
-
-
Bodner, S.M.1
Minna, J.D.2
Jensen, S.M.3
D'Amico, D.4
Carbone, D.5
Mitsudomi, T.6
Fedorko, J.7
Buchhagen, D.L.8
Nau, M.M.9
Gazdar, A.F.10
Linnoila, R.I.11
-
6
-
-
0030952502
-
Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry
-
Bonsing BA, Corver WE, Gorsira MCB, vanVliet M, Oud PS, Cornelisse CJ and Fleuren GJ (1997) Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry Cytometry 28. 11-24
-
(1997)
Cytometry
, vol.28
, pp. 11-24
-
-
Bonsing, B.A.1
Corver, W.E.2
Gorsira, M.C.B.3
VanVliet, M.4
Oud, P.S.5
Cornelisse, C.J.6
Fleuren, G.J.7
-
7
-
-
0028298872
-
Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes
-
Brown CR, Doxsey SJ, White E and Welch WJ (1994) Both viral (adenovirus E1B) and cellular (hsp70, p53) components interact with centrosomes. J. Cell. Phys 160: 47-60
-
(1994)
J. Cell. Phys
, vol.160
, pp. 47-60
-
-
Brown, C.R.1
Doxsey, S.J.2
White, E.3
Welch, W.J.4
-
8
-
-
0023925894
-
Expression in breast cancer
-
Cattoretti G, Rilke F, Andreola S, D'Amato L and Delia D (1988) Expression in breast cancer. Int. J Cancer 41: 178-183
-
(1988)
Int. J Cancer
, vol.41
, pp. 178-183
-
-
Cattoretti, G.1
Rilke, F.2
Andreola, S.3
D'Amato, L.4
Delia, D.5
-
9
-
-
0029862963
-
Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan
-
Danks MK, Garrett KE, Marion RC and Whipple DO (1996) Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan. Cancer Res. 56. 1664-1673
-
(1996)
Cancer Res.
, vol.56
, pp. 1664-1673
-
-
Danks, M.K.1
Garrett, K.E.2
Marion, R.C.3
Whipple, D.O.4
-
10
-
-
0030765192
-
Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure
-
Danks MK, Pawlik CA, Whipple DO and Wolverton JS (1997) Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure. Clin. Cancer Res. 3: 1731-1738
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 1731-1738
-
-
Danks, M.K.1
Pawlik, C.A.2
Whipple, D.O.3
Wolverton, J.S.4
-
11
-
-
0029827769
-
Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells
-
David-Pfeuty T, Chakrani F, Dry K and Nouvian-Dooghe Y (1996) Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. Cell Growth and Differentiation 7: 1211-1225
-
(1996)
Cell Growth and Differentiation
, vol.7
, pp. 1211-1225
-
-
David-Pfeuty, T.1
Chakrani, F.2
Dry, K.3
Nouvian-Dooghe, Y.4
-
12
-
-
0027953579
-
Loss of heterozygosity and p53 gene mutations in breast cancer
-
Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K and Smith HS (1994) Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54. 499-505
-
(1994)
Cancer Res
, vol.54
, pp. 499-505
-
-
Deng, G.1
Chen, L.C.2
Schott, D.R.3
Thor, A.4
Bhargava, V.5
Ljung, B.M.6
Chew, K.7
Smith, H.S.8
-
13
-
-
0027731748
-
Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas
-
Domagala W, Harenzga B, Szadowska A, Mariewski M, Weber K and Osbom M (1993) Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas. Am. J Pathol 142: 669-674
-
(1993)
Am. J Pathol
, vol.142
, pp. 669-674
-
-
Domagala, W.1
Harenzga, B.2
Szadowska, A.3
Mariewski, M.4
Weber, K.5
Osbom, M.6
-
14
-
-
0028294605
-
WAF1/CIP1 is induced upon p53-mediated growth arrest and apoptosis
-
El-Deiry WS, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B (1994) WAF1/CIP1 is induced upon p53-mediated growth arrest and apoptosis. Cancer Res, 54: 1169-1174
-
(1994)
Cancer Res
, vol.54
, pp. 1169-1174
-
-
El-Deiry, W.S.1
Harper, J.W.2
O'Conner, P.M.3
Velculescu, V.E.4
Canman, C.E.5
Jackman, J.6
Pietenpol, J.A.7
Burrell, M.8
Hill, D.E.9
Wang, Y.10
Wiman, K.G.11
Mercer, W.E.12
Kastan, M.B.13
Kohn, K.W.14
Elledge, S.J.15
Kinzler, K.W.16
Vogelstein, B.17
-
15
-
-
0031044559
-
p53 Immunostaining in differential diagnosis of pleural mesothelial proliferations
-
Esposito V, Balda A, DeLuca A, Claudio PP, Signoriello G, Bolognese A, Centonze P, Giordano GG, Caputi M, Baldi F and Giordano A (1997) p53 Immunostaining in differential diagnosis of pleural mesothelial proliferations. Anticancer Res 17: 733-736
-
(1997)
Anticancer Res
, vol.17
, pp. 733-736
-
-
Esposito, V.1
Balda, A.2
Deluca, A.3
Claudio, P.P.4
Signoriello, G.5
Bolognese, A.6
Centonze, P.7
Giordano, G.G.8
Caputi, M.9
Baldi, F.10
Giordano, A.11
-
16
-
-
0028171454
-
p53 Gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
-
Fan S, ElDiery WS, Bae I, Freeman J, Jondel D, Blatia K, Fornace AJ, Magrath I, Kohn KW and O'Connor PM (1994) p53 Gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54: 5824-5830
-
(1994)
Cancer Res.
, vol.54
, pp. 5824-5830
-
-
Fan, S.1
Eldiery, W.S.2
Bae, I.3
Freeman, J.4
Jondel, D.5
Blatia, K.6
Fornace, A.J.7
Magrath, I.8
Kohn, K.W.9
O'Connor, P.M.10
-
17
-
-
0027500246
-
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA damage
-
Fritsche M, Haessler C and Bradner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA damage. Oncogene 8. 307-318
-
(1993)
Oncogene
, vol.8
, pp. 307-318
-
-
Fritsche, M.1
Haessler, C.2
Bradner, G.3
-
18
-
-
0029971854
-
Modulation of DNA topoisomerase I activity by p53
-
Gobert C, Bracco L, Rossi F, Olivier M, Tazi J, Lavelle F, Larsen AK and Riou JF (1996) Modulation of DNA topoisomerase I activity by p53. Biochemistry 35: 5778-5786
-
(1996)
Biochemistry
, vol.35
, pp. 5778-5786
-
-
Gobert, C.1
Bracco, L.2
Rossi, F.3
Olivier, M.4
Tazi, J.5
Lavelle, F.6
Larsen, A.K.7
Riou, J.F.8
-
19
-
-
0028939453
-
Wild-type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line
-
Goldsmith ME, Gudas JM, Schneider E and Cowan KH (1995) Wild-type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line. J. Biol Chem. 270. 1894-1898
-
(1995)
J. Biol Chem.
, vol.270
, pp. 1894-1898
-
-
Goldsmith, M.E.1
Gudas, J.M.2
Schneider, E.3
Cowan, K.H.4
-
20
-
-
0023257034
-
Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma
-
Hazelton BJ, Houghton JA, Parham DM, Douglass EC, Torrance PM, Holt H and Houghton PJ (1987) Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res. 47: 4501-4507
-
(1987)
Cancer Res.
, vol.47
, pp. 4501-4507
-
-
Hazelton, B.J.1
Houghton, J.A.2
Parham, D.M.3
Douglass, E.C.4
Torrance, P.M.5
Holt, H.6
Houghton, P.J.7
-
21
-
-
0023691615
-
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 Tantigen
-
Jenkins JR, Chumakov P, Addison C, Sturzbecher HW and Wade-Evans A (1988) Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 Tantigen. J. Virol. 62: 3902-3906
-
(1988)
J. Virol.
, vol.62
, pp. 3902-3906
-
-
Jenkins, J.R.1
Chumakov, P.2
Addison, C.3
Sturzbecher, H.W.4
Wade-Evans, A.5
-
22
-
-
0030812331
-
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
-
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
-
(1997)
Cell
, vol.90
, pp. 809-819
-
-
Kaghad, M.1
Bonnet, H.2
Yang, A.3
Creancier, L.4
Biscan, J.C.5
Valent, A.6
Minty, A.7
Chalon, P.8
Lelias, J.M.9
Dumont, X.10
Ferrara, P.11
McKeon, F.12
Caput, D.13
-
23
-
-
0026318356
-
Participation of p53 protein in the cellular response to DNA damage
-
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51 6304-6311
-
(1991)
Cancer Res.
, vol.51
, pp. 6304-6311
-
-
Kastan, M.B.1
Onyekwere, O.2
Sidransky, D.3
Vogelstein, B.4
Craig, R.W.5
-
27
-
-
0027451668
-
p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
-
Lows SW, Ruley HE, Jacks T and Houseman E (1993) p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74. 957-967
-
(1993)
Cell
, vol.74
, pp. 957-967
-
-
Lows, S.W.1
Ruley, H.E.2
Jacks, T.3
Houseman, E.4
-
28
-
-
0025221676
-
Addition of fresh medium induces cell cycle and conformational changes in p53, a tumor suppressor protein
-
Milner J and Watson JV (1990) Addition of fresh medium induces cell cycle and conformational changes in p53, a tumor suppressor protein Oncogene 5: 11683-11690
-
(1990)
Oncogene
, vol.5
, pp. 11683-11690
-
-
Milner, J.1
Watson, J.V.2
-
29
-
-
0026543204
-
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
-
Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD and Gazdar A (1992) p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180
-
(1992)
Oncogene
, vol.7
, pp. 171-180
-
-
Mitsudomi, T.1
Steinberg, S.M.2
Nau, M.M.3
Carbone, D.4
D'Amico, D.5
Bodner, S.6
Oie, H.K.7
Linnoila, R.I.8
Mulshine, J.L.9
Minna, J.D.10
Gazdar, A.11
-
30
-
-
0030048389
-
Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage
-
Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier F and Zambetti GP (1996) Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell. Biol. 16: 1126-1137
-
(1996)
Mol. Cell. Biol.
, vol.16
, pp. 1126-1137
-
-
Moll, U.M.1
Ostermeyer, A.G.2
Haladay, R.3
Winkfield, B.4
Frazier, F.5
Zambetti, G.P.6
-
31
-
-
0026649648
-
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
-
Momand J, Zambetti GP, Olson DC, George D and Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245
-
(1992)
Cell
, vol.69
, pp. 1237-1245
-
-
Momand, J.1
Zambetti, G.P.2
Olson, D.C.3
George, D.4
Levine, A.J.5
-
32
-
-
0022637380
-
Specific interaction between the p53 cellular tumor antigen and major heat shock proteins
-
Pinhasi-Kimhi O, Michalovitz D, Ben-Zeev A and Oren M (1986) Specific interaction between the p53 cellular tumor antigen and major heat shock proteins. Nature (London) 320: 182-185
-
(1986)
Nature (London)
, vol.320
, pp. 182-185
-
-
Pinhasi-Kimhi, O.1
Michalovitz, D.2
Ben-Zeev, A.3
Oren, M.4
-
33
-
-
0025938198
-
Infrequent p53 gene mutations in medulloblastomas
-
Saylors RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B and Brodeur GM (1991) Infrequent p53 gene mutations in medulloblastomas Cancer Res. 51: 4721-4723
-
(1991)
Cancer Res.
, vol.51
, pp. 4721-4723
-
-
Saylors, R.L.1
Sidransky, D.2
Friedman, H.S.3
Bigner, S.H.4
Bigner, D.D.5
Vogelstein, B.6
Brodeur, G.M.7
-
34
-
-
0027050648
-
Wild-type p53 binds to the TATA-binding protein and represses transcription
-
Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ and Shenk T (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription Proc. Natl. Acad. Sci. USA 89: 12028-12032
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 12028-12032
-
-
Seto, E.1
Usheva, A.2
Zambetti, G.P.3
Momand, J.4
Horikoshi, N.5
Weinmann, R.6
Levine, A.J.7
Shenk, T.8
-
35
-
-
0026046039
-
Nuclear localization is essential for the activity of p53 protein
-
Shaulsky G, Goldfinger N, Tosky MS, Levine AJ and Rotter V (1991) Nuclear localization is essential for the activity of p53 protein Oncogene 6. 2055-2065
-
(1991)
Oncogene
, vol.6
, pp. 2055-2065
-
-
Shaulsky, G.1
Goldfinger, N.2
Tosky, M.S.3
Levine, A.J.4
Rotter, V.5
-
36
-
-
0030058617
-
The p53 gene in breast cancer Prognistic value of complementary DNA sequencing versus immunohistochemistry
-
Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L and Bergh J (1996) The p53 gene in breast cancer Prognistic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Ints 88: 173-182
-
(1996)
J Natl Cancer Ints
, vol.88
, pp. 173-182
-
-
Sjogren, S.1
Inganas, M.2
Norberg, T.3
Lindgren, A.4
Nordgren, H.5
Holmberg, L.6
Bergh, J.7
-
37
-
-
0028307813
-
Distinct conformations of p53 are observed at different stages of keratinocyte differentiation
-
Spandau DF (1994) Distinct conformations of p53 are observed at different stages of keratinocyte differentiation Oncogene 9. 1861-1868
-
(1994)
Oncogene
, vol.9
, pp. 1861-1868
-
-
Spandau, D.F.1
-
38
-
-
0025441236
-
cdc2 in mammalian cells: Implications for cell cycle control and oncogenesis
-
cdc2 in mammalian cells: implications for cell cycle control and oncogenesis Oncogene 5: 795-801
-
(1990)
Oncogene
, vol.5
, pp. 795-801
-
-
Sturzbecher, H.W.1
Maimets, T.2
Chumakov, P.3
Brain, R.4
Addison, C.5
Simanis, V.6
Rudge, K.7
Philp, R.8
Grimaldi, M.9
Court, W.10
Jenkins, J.R.11
-
39
-
-
0024452546
-
p53 a frequent target for genetic abnormalities in lung cancer
-
Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF and Minna JD (1989) p53 a frequent target for genetic abnormalities in lung cancer Science 246, 491-494
-
(1989)
Science
, vol.246
, pp. 491-494
-
-
Takahashi, T.1
Nau, M.M.2
Chiba, I.3
Birrer, M.J.4
Rosenberg, R.K.5
Vinocour, M.6
Levitt, M.7
Pass, H.8
Gazdar, A.F.9
Minna, J.D.10
-
40
-
-
0031044713
-
A Novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status
-
Thomas MD, McIntosh GG, Anderson JJ, MdKena DM, Parr AH, Johnstone R. Lennard TWJ, Horne CHW and Angus B (1997) A Novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status J. Clin. Pathol. 50: 143-147
-
(1997)
J. Clin. Pathol.
, vol.50
, pp. 143-147
-
-
Thomas, M.D.1
McIntosh, G.G.2
Anderson, J.J.3
Mdkena, D.M.4
Parr, A.H.5
Johnstone, R.6
Lennard, T.W.J.7
Horne, C.H.W.8
Angus, B.9
-
41
-
-
0026093508
-
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas
-
Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C and Walker RA (1991) Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Oncogene 6: 513-521
-
(1991)
Oncogene
, vol.6
, pp. 513-521
-
-
Varley, J.M.1
Brammar, W.J.2
Lane, D.P.3
Swallow, J.E.4
Dolan, C.5
Walker, R.A.6
-
42
-
-
0025271203
-
Association of human papillomavirus types 16 and 18 E6 proteins with p53
-
Wemess BA. Levine AJ and Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248. 76-79
-
(1990)
Science
, vol.248
, pp. 76-79
-
-
Wemess, B.A.1
Levine, A.J.2
Howley, P.M.3
-
43
-
-
0030948143
-
p53 Gene mutations and p53 protein expression in human soft tissue sarcomas
-
Yoo J, Lee HK, Kang CS, Park WS, Lee JY and Shim SI (1997) p53 Gene mutations and p53 protein expression in human soft tissue sarcomas. Arch. Pathol. Lab. Med 121: 395-399
-
(1997)
Arch. Pathol. Lab. Med
, vol.121
, pp. 395-399
-
-
Yoo, J.1
Lee, H.K.2
Kang, C.S.3
Park, W.S.4
Lee, J.Y.5
Shim, S.I.6
-
44
-
-
0027234492
-
A Comparison of the b iological activities of wild-type and mutant p53
-
Zambetti GP and Levine AJ (1993) A Comparison of the b iological activities of wild-type and mutant p53. FASEB J. 7. 855-865
-
(1993)
FASEB J.
, vol.7
, pp. 855-865
-
-
Zambetti, G.P.1
Levine, A.J.2
-
45
-
-
0028107740
-
Cytoplasmic localization of the mitogen-activated protein kinase activator MEK
-
Zheng CF and Guan KL (1994) Cytoplasmic localization of the mitogen-activated protein kinase activator MEK. J. Biol Chem. 269: 19947-19952
-
(1994)
J. Biol Chem.
, vol.269
, pp. 19947-19952
-
-
Zheng, C.F.1
Guan, K.L.2
|